Seattle Based Juno News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Seattle neurology startup Eliem Therapeutics raises $60M, two months after landing $80M May 24, 2021 at 11:03 am Bob Azelby. (Eliem Photo) New funding: Eliem Therapeutics raised $60 million to further development of its therapies for pain and depression. The fresh funding comes just two months after Eliem raised a $80 million round. The pipeline: Founded in 2019, the company has two lead drug candidates in development: ETX-810 for chronic pain and ETX-155 for major depressive disorder, hormone-related mood disorders, and focal onset seizures. Both are in Phase 2a clinical trials. ETX-810 i...

Sana Biotechnology went public before testing any treatments in people. The cell and gene therapy startup won't launch clinical trials for at least a year. Noted life sciences VCs Flagship Pioneering and Arch Venture Partners were its biggest shareholders pre-IPO. Cell and gene editing startup Sana Biotechnology's shares jumped more than 40% on its first day of trading, making one of its investors' stakes worth more than $1.5 billion.  The company sold 23.5 million shares at $25 apiece Thursday. Its stock price was up 40.40% at the end of the first day of trading, closing at $35.10 per share...